1.
Gangat N, Bleeker J, Lynch D, Olteanu H, Letendre L, Tefferi A. Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia. Haematologica 2022;107(10):2523-2526; https://doi.org/10.3324/haematol.2022.281398.